1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Favorable research and development initiatives by U.S private and public sector
5.1.1.2. Rising application of AI technologies in U.S pharmaceutical companies
5.1.2. Restraints
5.1.2.1. Capital intensive drug development and cumbersome process
5.1.3. Opportunities
5.1.3.1. Robust investment in clinical trials by pharmaceutical companies in U.S
5.1.3.2. Increasing inorganic growth strategies such as collaborations among key market players
5.1.4. Challenges
5.1.4.1. Lack of standard procedure from regulatory bodies for the process
5.2. Cumulative Impact of COVID-19

6. AI-based Clinical Trials Solution Provider Market, by Phase
6.1. Introduction
6.2. Phase-I
6.3. Phase-II
6.4. Phase-III

7. AI-based Clinical Trials Solution Provider Market, by Application
7.1. Introduction
7.2. Cardiovascular Diseases
7.3. Infectious Diseases
7.4. Metabolic Diseases
7.5. Neurological Diseases or Conditions
7.6. Oncology

8. AI-based Clinical Trials Solution Provider Market, by End User
8.1. Introduction
8.2. Academia
8.3. Others
8.4. Pharmaceutical Companies

9. California AI-based Clinical Trials Solution Provider Market

10. Florida AI-based Clinical Trials Solution Provider Market

11. Illinois AI-based Clinical Trials Solution Provider Market

12. New York AI-based Clinical Trials Solution Provider Market

13. Ohio AI-based Clinical Trials Solution Provider Market

14. Pennsylvania AI-based Clinical Trials Solution Provider Market

15. Texas AI-based Clinical Trials Solution Provider Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Antidote Technologies, Inc.
17.2. BioSymetrics
17.3. Deep 6 AI
17.4. GNS Healthcare
17.5. Google- Verily
17.6. Halo Health Systems
17.7. IBM Watson
17.8. Pharmaseal
17.9. Phesi
17.10. Unlearn.AI, Inc.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE, 2027
FIGURE 6. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-I, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-I, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-II, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-II, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-III, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-III, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY APPLICATION, 2027
FIGURE 15. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY METABOLIC DISEASES, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY METABOLIC DISEASES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY NEUROLOGICAL DISEASES OR CONDITIONS, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY NEUROLOGICAL DISEASES OR CONDITIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ONCOLOGY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 26. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY END USER, 2027
FIGURE 28. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ACADEMIA, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ACADEMIA, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 31. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY OTHERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: FPNV POSITIONING MATRIX
FIGURE 35. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 36. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-I, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-II, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHASE-III, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY METABOLIC DISEASES, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY NEUROLOGICAL DISEASES OR CONDITIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY ACADEMIA, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY OTHERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: SCORES
TABLE 18. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: BUSINESS STRATEGY
TABLE 19. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: PRODUCT SATISFACTION
TABLE 20. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: RANKING
TABLE 21. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 22. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: MERGER & ACQUISITION
TABLE 23. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 24. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 25. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: INVESTMENT & FUNDING
TABLE 26. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 27. UNITED STATES AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET: LICENSE & PRICING

Companies Mentioned

Antidote Technologies, Inc.
BioSymetrics
Deep 6 AI
GNS Healthcare
Google- Verily
Halo Health Systems
IBM Watson
Pharmaseal
Phesi
Unlearn.AI, Inc.